Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine David ShrayerHendrix BogaarsHarold Wanebo Original Article Pages: 277 - 282
Immune parameters of mice bearing human head and neck cancer Ari TaitzGuy PetruzzelliI. Young Original Article Pages: 283 - 291
The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma Teodoro PalomaresPedro BilbaoEmilio Barberá-Guillem Original Article Pages: 292 - 298
Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration Gregory P. AdamsJohn E. McCartneyLouis M. Weiner Original Article Pages: 299 - 306
Keyhole limpet hemocyanin contains Gal(β1–3)-GalNAc determinants that are cross-reactive with the T antigen Itzhak WirguinLjubica Suturkova-MilosevićNorman Latov Original Article Pages: 307 - 310
Interferon α enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer D. M. MahviJ. A. MadsenP. M. Sondel Original Article Pages: 311 - 314
Potentiation of antitumor effects of tumor necrosis factor α and interferon γ by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice Witold LasekAnna WańkowiczMarek Jakóbisiak Original Article Pages: 315 - 321
An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models Michael G. RosenblumLawrence CheungJames L. Murray Original Article Pages: 322 - 328
Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative Etsuko MasudaHiroshi Maeda Original Article Pages: 329 - 338
Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin Kalpana MujooLawrence CheungMichael G. Rosenblum Original Article Pages: 339 - 345
